Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).

This designation is in addition to Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation, all previously granted by the FDA for tividenofusp alfa in Hunter syndrome.

Hunter syndrome affects over 2,000 individuals, primarily males, in commercially accessible regions. With analysts maintaining a Strong Buy consensus and the company maintaining a healthy liquidity ...

While that is still possible, the operating system has become a mature platform. Features we used to have to shoehorn into the phone have become standard options. Today, Android smartphones are ...

Whether you're finding places, checking public transit schedules, or exploring new places, Google constantly adds features to make Maps more useful. While features like offline maps and multi-stop ...

On the complete opposite end of the spectrum, Nivola’s big swings as Aleksei Sytsevich/Rhino in J.C. Chandor’s Kraven the Hunter are, per consensus, the few highlights of the poorly received film.

After going hands-on with Monster Hunter Wilds during its open beta in October, I was left clamouring for more of what CAPCOM have been cooking up. Its directional shift also left me with more ...

Which features will help the handset stand out from the crowd? Update, Wednesday, Jan. 1, 2025: The Samsung community has been waiting to see if the Galaxy S25 family will have their preferred ...

Storyline: When his abusive father’s actions cause him to escape home, Kraven finds haven in a sanctuary and turns into a hunter only to know that he’s being hunted As a fan of Hollywood films ...